Newgenivf Group Limited Stock Fundamentals
| NIVF Stock | 1.06 0.08 7.02% |
NewGenIvf Group Limited fundamentals help investors to digest information that contributes to NewGenIvf Group's financial success or failures. It also enables traders to predict the movement of NewGenIvf Stock. The fundamental analysis module provides a way to measure NewGenIvf Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NewGenIvf Group stock.
At this time, NewGenIvf Group's Interest Expense is most likely to decrease significantly in the upcoming years. The NewGenIvf Group's current Selling And Marketing Expenses is estimated to increase to about 19.4 K, while Selling General Administrative is projected to decrease to roughly 1.4 M. NewGenIvf | Select Account or Indicator |
NewGenIvf Group Limited Company Profit Margin Analysis
NewGenIvf Group's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current NewGenIvf Group Profit Margin | (0.01) % |
Most of NewGenIvf Group's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NewGenIvf Group Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
NewGenIvf Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, NewGenIvf Group Limited has a Profit Margin of -0.0142%. This is 99.87% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The profit margin for all United States stocks is 98.88% lower than that of the firm.
NewGenIvf Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NewGenIvf Group's current stock value. Our valuation model uses many indicators to compare NewGenIvf Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NewGenIvf Group competition to find correlations between indicators driving NewGenIvf Group's intrinsic value. More Info.NewGenIvf Group Limited is considered to be number one stock in profit margin category among its peers. It also is considered to be number one stock in operating margin category among its peers . At this time, NewGenIvf Group's Net Loss is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value NewGenIvf Group by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.NewGenIvf Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NewGenIvf Group's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NewGenIvf Group could also be used in its relative valuation, which is a method of valuing NewGenIvf Group by comparing valuation metrics of similar companies.NewGenIvf Group is currently under evaluation in profit margin category among its peers.
NewGenIvf Fundamentals
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 2.04 M | ||||
| Shares Outstanding | 1.7 M | ||||
| Shares Owned By Insiders | 2.24 % | ||||
| Shares Owned By Institutions | 1.31 % | ||||
| Number Of Shares Shorted | 117.02 K | ||||
| Price To Book | 1.97 X | ||||
| Price To Sales | 0.34 X | ||||
| Revenue | 5.14 M | ||||
| Gross Profit | 1.48 M | ||||
| EBITDA | 384.31 K | ||||
| Net Income | (690.85 K) | ||||
| Total Debt | 332.55 K | ||||
| Book Value Per Share | (12.98) X | ||||
| Cash Flow From Operations | (857.36 K) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | 0.26 X | ||||
| Number Of Employees | 70 | ||||
| Beta | -0.3 | ||||
| Market Capitalization | 1.94 M | ||||
| Total Asset | 1.65 M | ||||
| Retained Earnings | (5.67 M) | ||||
| Working Capital | 79 K | ||||
| Net Asset | 1.65 M |
About NewGenIvf Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NewGenIvf Group Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NewGenIvf Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NewGenIvf Group Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 7.1 K | 6.8 K | |
| Total Revenue | 5.9 M | 5.6 M | |
| Cost Of Revenue | 4 M | 4 M | |
| Sales General And Administrative To Revenue | 0.28 | 0.18 | |
| Capex To Revenue | 0.01 | 0.01 | |
| Revenue Per Share | 0.85 | 0.57 | |
| Ebit Per Revenue | 0.01 | 0.01 |
Currently Active Assets on Macroaxis
When determining whether NewGenIvf Group is a strong investment it is important to analyze NewGenIvf Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact NewGenIvf Group's future performance. For an informed investment choice regarding NewGenIvf Stock, refer to the following important reports:Check out NewGenIvf Group Piotroski F Score and NewGenIvf Group Altman Z Score analysis. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NewGenIvf Group. If investors know NewGenIvf will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NewGenIvf Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NewGenIvf Group is measured differently than its book value, which is the value of NewGenIvf that is recorded on the company's balance sheet. Investors also form their own opinion of NewGenIvf Group's value that differs from its market value or its book value, called intrinsic value, which is NewGenIvf Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NewGenIvf Group's market value can be influenced by many factors that don't directly affect NewGenIvf Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NewGenIvf Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if NewGenIvf Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NewGenIvf Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.